Clinical trial
Radiation-Free Therapy for the Initial Treatment of Good Prognosis Early Non-bulky HL, Defined by a Low Metabolic Tumor Volume and a Negative Interim PET After 2 Chemotherapy Cycles- RAFTING
NCT04866654 is registered in ClinicalTrials.gov with Medical University of Gdansk as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Radiation-Free Therapy for the Initial Treatment of Good Prognosis Early Non-bulky HL, Defined by a Low Metabolic Tumor Volume and a Negative Interim PET After 2 Chemotherapy Cycles- RAFTING
- Lead sponsor
- Medical University of Gdansk
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- March 4, 2021
- Completion date
- July 2, 2026
- Enrollment
- 160 (estimated)
- Sites
- 27
Conditions
As the registry lists them; a condition with its own page is linked.
hodgkin lymphoma